News Category
Regentis Biomaterials is progressing its GelrinC cartilage regeneration technology through clinical trials, FDA submission preparation, European comme...
Quantum BioPharma is progressing its two-pronged approach to neurological health, targeting multiple sclerosis with Lucid-MS and alcohol misuse with u...
Quantum BioPharma progresses its two-pronged approach to neurological health, advancing Lucid-MS for multiple sclerosis and commercializing unbuzzd fo...
VERAXA Biotech's proprietary BiTAC platform and pipeline of next-generation antibody therapeutics could attract substantial financial commitments, pos...
A Spanish patient's brain lesion initially mistaken for cancer was found to be pork tapeworm cysts, underscoring the importance of proper pork cooking...
Lantern Pharma announced its upcoming webcast to discuss Q2 2026 results, clinical progress, and the commercial availability of its withZeta.ai platfo...
VERAXA Biotech has moved its VXA-222 bispecific antibody-drug conjugate into the next development stage and expanded its intellectual property, streng...
A novel liquid biopsy offers a simpler method to forecast which advanced lung cancer patients will benefit from immunotherapy, potentially aiding drug...
GeoVax announced completed manufacturing, regulatory, clinical, and preclinical milestones for its mpox/smallpox vaccine GEO-MVA, positioning it for a...
Researchers at Nagoya University have discovered that the C3 protein, when produced within tumors, may boost the effectiveness of immunotherapy, offer...
NeuroThera Labs has launched a Phase IIb clinical trial at Yale Child Study Center for SCI-110, a novel cannabinoid-based treatment for Tourette Syndr...
New research shows that even low levels of physical activity are associated with reduced risks of stroke and death in people with atrial fibrillation,...
The United States has recorded 2,371 measles cases in 2025, the highest in three decades, with outbreaks in Utah, South Carolina, and Arizona, undersc...
Quantum BioPharma's MS imaging study with Massachusetts General Hospital shows promising early results, potentially improving how myelin damage is mea...
Biotech Labz Supply Inc has expanded its online catalog to include 11 high-purity research peptides, each supplied with batch-specific COA documentati...
Oncotelic Therapeutics will showcase its recent clinical and technological advancements at the OTCQB Virtual Investor Conference, highlighting progres...
Tonix Pharmaceuticals announced FDA feedback supporting its planned adaptive Phase 2 study of TNX-4800, a long-acting monoclonal antibody for Lyme dis...
Helus Pharma announced the appointment of Michael Halstead as CEO, bringing extensive biopharmaceutical leadership to guide the company through Phase ...
New independent research suggests cross-reactive immunity may extend across ebolavirus species, bolstering the strategic value of GeoVax's MVA-based f...
Quantum BioPharma's pilot MS imaging study with Massachusetts General Hospital has reached halfway enrollment, with early PET imaging data showing enc...
Center for Dental Implants now offers both surgical placement and restorative services for dental implants in Aventura, FL, providing a single-locatio...
VERAXA Biotech has promoted Dr. Christoph Erkel to Chief Scientific Officer as it advances its proprietary BiTAC® technology platform toward clinical ...
A new preclinical study indicates that an experimental therapy containing vitamin B12 could stop the progression of glioblastoma multiforme, the deadl...
VolitionRx announced increasing clinical evidence supporting its Nu.Q NETs assay as a biomarker for sepsis, with multiple studies showing its ability ...
Instinct Bio announced a strategic collaboration with INVITRX to expand its GENREVER brand into the U.S. market and advance regenerative medicine init...
VERAXA Biotech has expanded its intellectual property portfolio with new patent filings for its BiTAC-TCE and BiTAC-ADC platforms, aiming to protect i...
VERAXA Biotech AG has appointed Dr. Christoph Erkel as CSO to lead scientific strategy and accelerate its BiTAC(R) platform toward clinical developmen...
New research published in the Journal of the American Heart Association reveals that 28% of U.S. adults with high blood pressure may be newly eligible...
Greenland Mines (NASDAQ: GRML) received a Canadian patent for its Klotho gene therapy technology, expanding its IP portfolio and advancing lead candid...
Quantum BioPharma (NASDAQ: QNTM) executive outlines plans for its MS drug candidate Lucid-MS and the commercial product unbuzzd, highlighting a dual a...
Regentis Biomaterials is building commercial and regulatory momentum for its GelrinC hydrogel-based cartilage repair implant, with strategic industry ...
Greenland Mines Ltd. announced that Innovation, Science and Economic Development Canada has granted a patent covering Klotho-based gene therapies for ...
A new research initiative aims to understand why some individuals with cancer risk factors never develop the disease, focusing on autoantibodies and t...
NanoViricides awaits regulatory approval in the DRC to begin a Phase II trial of its NV-387 Oral Gummies for Bundibugyo ebolavirus, offering a potenti...
Lantern Pharma announced EMA approval for a biomarker-guided trial of LP-184 in advanced bladder cancer, potentially offering a new treatment option f...
Physician reports from a large cohort of epilepsy patients treated with NeuroOne's OneRF Ablation System demonstrate meaningful reductions in seizure ...
GeoVax Labs reported a net loss of $4.4 million for Q2 2026 and provided updates on its lead programs, including plans to initiate a pivotal immunobri...
VERAXA Biotech announced the advancement of its bispecific antibody-drug conjugate program VXA-222 after OmniAb completed key discovery work, moving t...
Quantum BioPharma outlines its strategy for advancing Lucid-MS, a multiple sclerosis drug candidate, to Phase 2 trials while commercializing unbuzzd, ...
Onco-Innovations Limited is progressing its lead PNKP inhibitor ONC010 by scaling up manufacturing, securing partnerships for formulation and regulato...
A randomized clinical trial found that providing heart failure patients in the Navajo Nation with eight weeks of medically tailored meals incorporatin...
Research published in Nature Medicine indicates that experimental immunotherapy may offer new hope for patients with deadly pediatric brain and spinal...
Tonix Pharmaceuticals will report Q2 2026 financial results and operational highlights on August 10, 2026, with a conference call to discuss progress ...
VERAXA Biotech announced the advancement of its bispecific antibody-drug conjugate program VXA-222 after OmniAb completed discovery work, moving the c...
Onco-Innovations integrates a PNKP inhibitor, nanoparticle delivery, and AI platform to tackle cancer drug resistance, trial failures, and delivery ch...
Researchers at Peking Union Medical College Hospital have proposed a tiered genetic framework for Behçet's spectrum disorders that could transform dia...
NanoViricides announced a $3.8 million registered direct offering to institutional investors, providing capital to advance its broad-spectrum antivira...
VERAXA Biotech received Scientific Advice from Germany's Paul-Ehrlich-Institute supporting its lead BiTAC®-TCE program, reducing development uncertain...
